These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8256623)

  • 1. Active immunization of children with leukemias and lymphomas against infection by hepatitis B virus.
    Rokicka-Milewska R; Jackowska T; Sopyło B; Kacperska E; Seyfried H
    Acta Paediatr Jpn; 1993 Oct; 35(5):400-3. PubMed ID: 8256623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Engerix B vaccine in prophylaxis of hepatitis B virus infection in children with diabetes].
    Tańska A
    Wiad Lek; 1994 Feb; 47(3-4):107-10. PubMed ID: 7975633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults.
    Levie K; Gjorup I; Skinhøj P; Stoffel M
    Scand J Infect Dis; 2002; 34(8):610-4. PubMed ID: 12238579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia.
    Yetgin S; Tavil B; Aytac S; Kuskonmaz B; Kanra G
    Leuk Res; 2007 Apr; 31(4):493-6. PubMed ID: 16930691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against hepatitis B in children with chronic hematologic diseases treated with immunosuppression].
    Jackowska T; Rokicka-Milewska R; Madaliński K; Kacperska E; Zupańska B; Muszyńska-Rosłan K; Kaczmarski M
    Przegl Epidemiol; 1997; 51(3):255-65. PubMed ID: 9411496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of immunization against hepatitis B virus infection in children with cancer.
    Meral A; Sevinir B; Günay U
    Med Pediatr Oncol; 2000 Jul; 35(1):47-51. PubMed ID: 10881007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of Russian vaccines in the prophylaxis of virus hepatitis B].
    Solov'eva IL; Kusel'man AI; Kalmanova VP; Kostinov MP
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):100-5. PubMed ID: 15773414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
    Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
    Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
    Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
    Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against hepatitis B in children from endemic zone: evaluation of the antibody response against the DNA recombinant vaccine (Engerix B-20 MCG).
    Ferreira CR; Yoshida CF; Mercadante LA; Gomes DF; Oliveira JM; França MS; Sidoni M; Ennes IC; Baptista ML; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):89-92. PubMed ID: 8278748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.